Literature DB >> 31793154

Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics.

Riccardo M Inciardi1, Andrea Rossi1, Corinna Bergamini1, Giovanni Benfari1, Caterina Maffeis1, Carmen Greco1, Andrea Drago1, Marco Guazzi2, Flavio L Ribichini1, Mariantonietta Cicoira1.   

Abstract

AIMS: To assess the association between mitral regurgitation (MR) and left atrial (LA) structural and functional remodelling and their effect on pulmonary haemodynamics. METHODS AND
RESULTS: Consecutive unselected patients undergoing comprehensive echocardiography were enrolled. Parameters of cardiac structure and function were obtained as well as mitral effective regurgitant orifice area (ERO) and estimation of pulmonary artery systolic pressure (PASP). Measures of LA structure [LA volume (LAV)] and function [peak atrial longitudinal strain (PALS), peak atrial contraction strain (PACS) and conduit strain (CS)] were also calculated. The study population included 102 patients (mean age 70 ± 14 years, 42% women), with a mean ejection fraction of 52 ± 13%. MR was classified as organic due to mitral valve prolapse in 14 patients (14%) and functional in 88 patients (86%). Mean ERO was 0.12 ± 0.12 cm2 and 86 patients (84%) had an ERO ≤0.2 cm2 . ERO was significantly associated with worse measures of LA structure and function. Despite the low burden of MR, the association remained significant after adjusting for clinical and echocardiographic confounders (β: 3.7, P = 0.022 for LAV; β: -3.0, P = 0.003 for PALS; β: -1.8, P = 0.027 for PACS) and was significantly related with functional MR (P for interaction <0.001). ERO was also significantly associated with PASP, and measures of LA function (PALS and PACS) significantly modified this relationship (P for interaction <0.001).
CONCLUSIONS: Even a mild degree of MR contributes to LA remodelling and this relationship plays an active role in pulmonary circulation, suggesting a potential mechanism by which these parameters contribute to the development of heart failure.
© 2019 European Society of Cardiology.

Entities:  

Keywords:  Echocardiography; Heart failure; Left atrium; Mitral regurgitation; Pulmonary haemodynamics

Mesh:

Year:  2019        PMID: 31793154     DOI: 10.1002/ejhf.1677

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  14 in total

Review 1.  Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction.

Authors:  Chakradhari Inampudi; Daniel Silverman; Marc A Simon; Peter J Leary; Kavita Sharma; Brian A Houston; Jean-Luc Vachiéry; Francois Haddad; Ryan J Tedford
Journal:  Chest       Date:  2021-08-12       Impact factor: 9.410

2.  Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure?

Authors:  Ravi B Patel; Sanjiv J Shah; Riccardo M Inciardi
Journal:  Eur J Heart Fail       Date:  2022-01-19       Impact factor: 15.534

Review 3.  Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages.

Authors:  Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi
Journal:  Front Cardiovasc Med       Date:  2022-01-13

4.  Incremental Prognosis by Left Atrial Functional Assessment: The Left Atrial Coupling Index in Patients With Floppy Mitral Valves.

Authors:  Benjamin Essayagh; Giovanni Benfari; Clémence Antoine; Joseph Maalouf; Sorin Pislaru; Prabin Thapa; Hector I Michelena; Maurice Enriquez-Sarano
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

5.  Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure.

Authors:  Caterina Maffeis; Riccardo M Inciardi; Muhammad Shahzeb Khan; Elvin Tafciu; Corinna Bergamini; Giovanni Benfari; Martina Setti; Flavio L Ribichini; Mariantonietta Cicoira; Javed Butler; Andrea Rossi
Journal:  Int J Cardiovasc Imaging       Date:  2021-08-30       Impact factor: 2.357

6.  Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction.

Authors:  Caterina Maffeis; Andrea Rossi; Lorenzo Cannata; Camilla Zocco; Evgeny Belyavskiy; Aravind Kumar Radhakrishnan; Anna Feuerstein; Daniel Armando Morris; Elisabeth Pieske-Kraigher; Burkert Pieske; Frank Edelmann; Pier Luigi Temporelli
Journal:  ESC Heart Fail       Date:  2022-01-05

7.  Cardiac Structure and Function and Diabetes-Related Risk of Death or Heart Failure in Older Adults.

Authors:  Riccardo M Inciardi; Brian Claggett; Deepak K Gupta; Susan Cheng; Jiankang Liu; Justin B Echouffo Tcheugui; Chiadi Ndumele; Kunihiro Matsushita; Elizabeth Selvin; Scott D Solomon; Amil M Shah; Hicham Skali
Journal:  J Am Heart Assoc       Date:  2022-03-05       Impact factor: 6.106

8.  Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction.

Authors:  Caterina Maffeis; Daniel Armando Morris; Evgeny Belyavskiy; Martin Kropf; Aravind Kumar Radhakrishnan; Veronika Zach; Cristina Rozados da Conceicao; Tobias Daniel Trippel; Elisabeth Pieske-Kraigher; Andrea Rossi; Burkert Pieske; Frank Edelmann
Journal:  ESC Heart Fail       Date:  2020-12-08

9.  Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction.

Authors:  Andrea Rossi; Erberto Carluccio; Matteo Cameli; Riccardo M Inciardi; Giulia Elena Mandoli; Andreina D'Agostino; Paolo Biagioli; Caterina Maffeis; Nicola R Pugliese; Maria Concetta Pastore; Anna Mengoni; Roberto Pedrinelli; Michael Henein; Frank L Dini
Journal:  ESC Heart Fail       Date:  2021-11-02

10.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.